Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone vs Laser Photocoagulation in Diabetic Macular Edema
NCT02121262Phase 3Completed
- Sponsor
- Allergan
- Start
- Jan 2016
- Primary completion
- Nov 2019
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
Phase 3, randomised, open-label trial of dexamethasone in diabetic macular edema (DME) (2 arms), sponsored by Allergan. Primary endpoint: Best Corrected Visual Acuity at 12 months. Started Jan 2016; status: completed.
02
Drugs
dexamethasone
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT02121262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02121262.